Filter
903
Text search:
DNA
Featured
Recommendations
102
New Publications
236
Language
Document type
No document type
523
Studies & Reports
122
Guidelines
122
Manuals
54
Fact sheets
34
Strategic & Response Plan
21
Training Material
14
Resource Platforms
5
Situation Updates
3
Infographics
3
Brochures
1
Videos
1
Countries / Regions
India
76
Global
24
Kenya
22
Tanzania
21
Zambia
19
Malawi
17
Western and Central Europe
17
Ethiopia
16
South Africa
16
Nepal
15
Germany
15
Bangladesh
14
Brazil
13
Africa
13
Mozambique
12
Indonesia
11
Latin America and the Carribbean
11
Nigeria
10
Ghana
10
Uganda
9
Namibia
9
Zimbabwe
8
Philippines
8
Rwanda
7
Paraguay
7
Syria
6
Lesotho
6
Asia
6
Liberia
5
Argentina
5
Myanmar / Burma
5
Senegal
4
USA
4
Eswatini/ Swaziland
4
Botswana
4
Angola
4
West and Central Africa
4
Middle East and North Africa
4
Eastern Europe
4
Sierra Leone
3
Congo, Democratic Republic of
3
Cameroon
3
Cambodia
3
Thailand
3
Venezuela
3
Burkina Faso
2
Haiti
2
Pakistan
2
Iraq
2
Lebanon
2
Peru
2
Ukraine
2
Bolivia
2
Madagascar
2
East and Southern Africa
2
United Kingdom
2
Guinea
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Togo
1
Somalia
1
South Sudan
1
Afghanistan
1
Turkey
1
Chad
1
China
1
Colombia
1
Yemen
1
South–East Asia Region
1
Mongolia
1
Timor Leste/ East Timor
1
Russia
1
Vietnam
1
North America
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
358
Clinical Guidelines
124
Pharmacy & Technologies
33
Public Health
32
Women & Child Health
26
Key Resources
24
Capacity Building
12
Toolboxes
HIV
89
TB
88
NTDs
67
COVID-19
50
Mental Health
33
AMR
31
Rapid Response
30
Refugee
25
Planetary Health
22
Pharmacy
16
Caregiver
15
NCDs
14
Ebola
12
Natural Hazards
11
Specific Hazards
9
Cholera
7
Conflict
7
Zika
7
Global Health Education
6
Disability
3
Polio
3
Social Ethics
2
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f
...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
The Interim Guidance for Risk Communication and Community Engagement (RCCE) outlines recommendations, considerations and methods to raise awareness, manage risk perception, maintain trust and proactively support people at risk to make informed decisions to protect themselves and others from monkeypo
...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’
...
Guía de medicamentos esenciales para primer nivel de atención – Edición 2019
Desde el 2010, los Estados miembros de la Organización Panamericana
de la Salud (OPS) han asumido el compromiso de impulsar la eliminación de la transmisión materno infantil (ETMI) de la infección por el VIH y la sífilis. Estos compromisos se renovaron y ampliaron en el año 2016 mediante la
...
Los objetivos de las guías son brindar directrices para optimizar el cuidado de la mayoría de los pacientes afectados por los VHB y VHC. Sin embargo, no reemplazan el criterio médico en la valoración y abordaje del paciente individual. En situaciones especiales, el mejor enfoque en el diagnóst
...
Resumen para Equipos de Salud Edición 2021-2022
Las presentes recomendaciones se encuentran dirigidas a los miembros del equipo de salud que asisten niñas, niños y adolescentes (NNyA) que viven con VIH. También se dirigen a los responsables jurisdiccionales que participan en el proceso de gesti
...
Peru celebrates 200 years of independence in 2021. Over this period of independent life, and despite the turbulent socio-political scenarios, from internal armed conflict to economic crisis to political instability over the last 40 years, Peru has experienced major changes on its epidemiological and
...
Esta carpeta ofrece información básica acerca de la estrategia de tamizaje basada en el test de VPH. Tiene como principales destinatariosa los integrantes del equipo de salud que realizan las tomas de las muestras para el tamizaje en las provincias que incorporaron esta nueva tecnología [ginecól
...
El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medicamento de primera elección en todos los casos con d
...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
In 2013, WHO and the Foundation for Innovative New Diagnostics convened a meeting of Buruli ulcer experts in Geneva, Switzerland (9) at which two priority unmet needs in diagnosis were identified:
a diagnostic test for early detection of Buruli ulcer in symptomatic patients with sufficient positive
...
The Global Task Force on Cholera Control (GTFCC) launched Ending Cholera: A Global
Roadmap to 2030 (Global Roadmap) (1), a strategy that aims to reduce global cholera
deaths by 90% and eliminate the disease in at least 20 countries by 2030. It is
organized according to three main axes:
• E
...
Le Groupe spécial mondial de lutte contre le choléra (GTFCC) a lancé Mettre fin au choléra :
Une feuille de route mondiale pour 2030 (la Feuille de route mondiale) (1). Cette stratégie vise
à réduire de 90 % le nombre de décès dus au choléra dans le monde et à mettre fin à la
malad
...
